Merus competitive analysis

Loading summary...

Explore patent oppositions filed by Merus against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSNov 7, 2018

Explore Merus's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 24, 2021Antibody Producing Non-Human Mammals1
May 6, 2020Method And Apparatus For Compensating Non-Active Currents In Electrical Power Networks1
Jun 28, 2017Generation Of Binding Molecules2

Latest publications and patents of Merus New

Explore the latest publications and patents granted to Merus, showcasing their recent innovations and technological advancements.

Last updated on: Oct 17, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Merus

Nov 24, 2021Antibody Producing Non-Human MammalsGranted And Under Opposition
May 6, 2020Method And Apparatus For Compensating Non-Active Currents In Electrical Power NetworksRevoked
Jun 28, 2017Generation Of Binding MoleculesRevoked

Latest PTAB cases involving Merus

Discover the latest PTAB cases involving Merus, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 23, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merus

IPR2025-00604Feb 11, 2025XENCORMERUSTrial Instituted
IPR2025-00605Feb 11, 2025XENCORMERUSTrial Instituted

Peer Comparison New

IP litigation analysis comparing Merus with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MERUS13 - 2
REGENERON PHARMACEUTICALS3894931
XENCOR - 22 -